Fig. 1 · Structure

Documents & Downloads

METTL1-WDR4-IN-1

METTL1-WDR4 Inhibitor

METTL1-WDR4-IN-1 is a selective competitive inhibitor of the METTL1-WDR4 methyltransferase complex, with an IC50 of 144 μM. This compound effectively inhibits m7G methyltransferase activity, resulting in decreased PKM2 protein expression and disruption of the METTL1/PKM2/H3K9la positive feedback loop. Additionally, METTL1-WDR4-IN-1 impairs PKM2 nuclear translocation and consequently inhibits CD155 transcriptional activation. It exhibits potential in reducing tumor cell proliferation, altering glycolytic metabolism, and enhancing immune responses by restoring NK cell and CD8+ T cell function. This reagent is valuable in the study of immunotherapy for colorectal cancer and is ideally combined with PKM2 inhibitors to improve anti-tumor efficacy.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 374705-10-9
Applications METTL1-WDR4 Inhibitor
Formula C8H11N5O2S
Molecular Weight 241.27
SMILES
S=C1N=C2C(N1)=C(N)N=CN2CC(CO)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...